[1]
Kus, C.; Ayhan-Kılcıgil, G.; Can-Eke, B.; Iscan, M. Synthesis and antioxidant properties of some novel benzimidazole derivatives on lipid peroxidation in the rat liver. Arch. Pharm. Res., 2004, 27, 156-163.
[2]
Ayhan-Kılcıgil, G.; Kus, C.; Coban, T.; Can-Eke, B.; Iscan, M. Synthesis and antioxidant properties of novel benzimidazole derivatives. J. Enzyme Inhib. Med. Chem., 2004, 19, 129-135.
[3]
Zerner, B. Recent advances in the chemistry of an old enzyme, urease. Bioorg. Chem., 1991, 19, 116-131.
[4]
Krajewska, B. Ureases: Roles, properties and catalysis. Wiad Chem., 2002, 56, 223-253.
[5]
Ligabue-Braun, R.; Andreis, F.C.; Verli, H.; Carlini, C.R. 3-to-1: Unraveling structural transitions in ureases. Naturwissenschaften, 2013, 100(5), 459-467.
[6]
Mobley, H.L.; Island, M.D.; Hausinger, R.P. Molecular biology of microbial ureases. Microbiol. Rev., 1995, 59(3), 451-480.
[7]
Sipponen, P.; Hyvärinen, H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand. J. Gastroenterol., 2009, 3-6.
[8]
Amtul, Z.; Rahman, A.U.; Siddiqui, R.A.; Choudhary, M.I. Chemistry and mechanism of urease inhibition. Curr. Med. Chem., 2002, 9(14), 1323-1348.
[9]
Velík, Y.; Baliharová, J.; Fink-Gremmels, V.; Bull, J.; Lamka, S.; Skálová, J.L. Benzimidazole drugs and modulation of biotransformation enzymes. Res. Vet. Sci., 2004, 76(2), 95-108.
[10]
Kosikowska, P.; Berlicki, L. Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review. Expert Opin. Ther. Pat., 2011, 21(6), 945-957.
[11]
Spasov, A.A.; Yozhitsa, I.N.; Bugaeva, L.I.; Anisimova, V.A. Benzimidazole derivatives: Spectrum of pharmacological activity and toxicological properties (a review). Pharm. Chem. J., 1999, 33, 232-243.
[12]
Bhattacharya, S.; Chaudhuri, P. Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes. Curr. Med. Chem., 2008, 15, 1762-1777.
[13]
Khokra, S.L.; Choudhary, D. Benzimidazole an important scaffold in drug discovery. Asian J. Biochem. Pharm. Res., 2011, 3(1), 476-486.
[14]
Ayhan-Kilcigil, G.; Kus, C.; Ozdamar, E.D.; Can-Eke, B.; Iscan, M. Synthesis and antioxidant capacities of some new benzimidazole derivatives. Arch. Pharm. , 2007, 340(11), 607-611.
[15]
Sharma, D.; Narasimhan, B.; Kumar, P.; Judge, V.; Narang, R.; Clercq, E.D.; Balzarini, Ö. Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles. J. Enzyme Inhib. Med. Chem., 2009, 24(5), 1161-1168.
[16]
Abonia, R.; Cortes, E.; Insuasty, B.; Quiroga, J.; Nogueras, M. Cobo, Synthesis of novel 1, 2, 5-trisubstituted benzimidazoles as potential antitumor agents. J. Eur. J. Med. Chem., 2011, 46(9), 4062-4070.
[17]
Srivastava, S.K.; Srivastava, S.; Srivastava, S.D. Synthesis of new 1, 2, 4-triazolo-thiadiazoles and its 2-oxoazetidines as antimicrobial, anticonvulsant and anti-inflammatory agents. Ind. J. Chem. Sect., 2002, 41B(11), 2357-2363.
[18]
Holla, B.S.; Rao, B.S.; Sarojini, B.K.; Akberali, P.M.; Kumari, N.S. Synthesis and studies on some new fluorine containing triazolothiadiazines as possible antibacterial, antifungal and anticancer agents. Eur. J. Med. Chem., 2006, 41(5), 657-663.
[19]
Bhandari, S.V.; Bothara, K.G.; Raut, M.K.; Patil, A.A.; Sarkate, A.P.; Mokale, V.J. Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel s-substituted phenacyl-1, 3, 4-oxadiazole-2-thiol and schiff bases of diclofenac acid as nonulcerogenic derivatives. Bioorg. Med. Chem., 2008, 16(4), 1822-1831.
[20]
Menteşe, E.; Karaali, N.; Yilmaz, F.; Ülker, S.; Kahveci, B. Microwave-assisted synthesis and biological evaluation of some benzimidazole derivatives containing a 1, 2, 4-triazol ring. Arch. Pharm. , 2013, 346(7), 556-561.
[21]
Demirayak, S.; Mohsen, A.U.; Karaburun, A.Ç. Synthesis and anticancer and anti-HIV testing of some pyrazino[1, 2-a] benzimidazole derivatives. Eur. J. Med. Chem., 2002, 37(3), 255-260.
[22]
Abdel-Mohsen, H.T.; Ragab, F.A.F.; Ramla, M.M.; El Diwani, H.I.E. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. Eur. J. Med. Chem., 2010, 45(6), 2336-2344.
[23]
Rice-Evans, C.; Diplock, A.T. Techniques in free radical research. Elsevier Science, 1. Edition, Amsterdam, 1991, 22, 1-290.
[24]
Yin, H.; Xu, L.; Porter, N.A. Free radical lipid peroxidation: Mechanisms and analysis. Chem. Rev., 2011, 111(10), 5944-5972.
[25]
Griffits, H.R.; Lunec, J.; Aruoma, O.I.; Halliwell, B. Moleculer biology of free radicals in human diseases; Oica. Int, 1998, pp. 327-366.
[26]
Andreadou, I.; Tasouli, A.; Bofilis, E.; Chrysselis, M.; Rekka, E.; Tsantili-Kakouliou, A.; Iliodromitis, E.; Siatra, T.; Kremastinos, D.T. Antioxidant activity of novel indole derivatives and protection of the mycardial damage in rabbits. Chem. Pharm. Bull. , 2002, 50, 165-168.
[27]
Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical
method to evaluate antioxidant activity LWT-Food Sci. Technol, 1995, 28(1), 25-30.
[28]
Arnao, M.B.; Cano, A.; Acosta, M. The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chem., 2001, 73(2), 239-244.
[29]
Oyaizu, M. Studies on products of browning reactions: Antioxidative activities of products of browning reaction prepared from glucosamine. Japan. J. Nutr., 1986, 44(6), 307-315.
[30]
Van Slyke, D.D.; Archibald, R.M. Manometric, titrimetric and colometric methods for measurements of urease activity. J. Biol. Chem., 1944, 154, 623-642.
[31]
Alam, N.; Hossain, M.; Khali, M.; Moniruzzaman, M.; Sulaiman, S.; Gan, S. High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis. BMC Complement. Altern. Med., 2011, 11, 65-73.
[32]
Soares, J.R.; Dinis, T.C.; Cunha, A.P.; Almeida, L.M. Antioxidant activities of some extracts of Thymus zygis. Free Radic. Res., 1997, 26, 469-478.
[33]
Leong, L.P.; Shui, G. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chem., 2002, 76, 69-75.
[34]
Arshad, T.; Khan, K.M.; Rasool, N.; Salar, U.; Hussain, S.; Asghar, H.; Ashraf, M.; Wadood, A.; Riaz, M.; Perveen, S.; Taha, M.; Ismail, N.H. 5-Bromo-2-aryl benzimidazole derivatives as non-cytotoxic potential dual inhibitors of a-glucosidase and urease enzymes. Bioorg. Chem., 2017, 72, 21-31.